ELDN · Company research
Eledon Pharmaceuticals, Inc. Common Stock (ELDN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A kidney transplant study will spotlight what patients report on Oct. 23 - Stock Titan | A kidney transplant study will spotlight what patients report on Oct. 23 Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals, Inc. (ELDN) Stock Price, News, Earnings & Company Profile - RTTNews | Eledon Pharmaceuticals, Inc. (ELDN) Stock Price, News, Earnings & Company Profile RTTNews | View source ↗ | RTTNews | Sep 23, 2026 | neutral | 0 | 0.6 |
| No reported rejections followed Eledon’s drug after six months, versus seven for tacrolimus. Phase 3 is expected in Q4 2026. - Stock Titan | No reported rejections followed Eledon’s drug after six months, versus seven for tacrolimus. Phase 3 is expected in Q4 2026. Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| A treatment to prevent kidney transplant rejection will be presented Sept. 22 - Stock Titan | A treatment to prevent kidney transplant rejection will be presented Sept. 22 Stock Titan | View source ↗ | Stock Titan | Sep 9, 2026 | neutral | 0 | 0.6 |
| Eledon: At The Center Of The Next Medical Frontier (NASDAQ:ELDN) - Seeking Alpha | Eledon: At The Center Of The Next Medical Frontier (NASDAQ:ELDN) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 27, 2026 | neutral | 0 | 0.6 |
| Here's Why We're Watching Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Situation - Simply Wall Street | Here's Why We're Watching Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Situation Simply Wall Street | View source ↗ | Simply Wall Street | Jul 25, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals stock initiated at Buy by Rodman & Renshaw - Investing.com | Eledon Pharmaceuticals stock initiated at Buy by Rodman & Renshaw Investing.com | View source ↗ | Investing.com | Jul 21, 2026 | neutral | 0 | 0.6 |
| ELDN Forecast — Price Target — Prediction for 2027 - TradingView | ELDN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals, Inc. (ELDN) Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation - Slideshow (NASDAQ:ELDN) 2026-06-22 - Seeking Alpha | Eledon Pharmaceuticals, Inc. (ELDN) Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation - Slideshow (NASDAQ:ELDN) 2026-06-22 Seeking Alpha | View source ↗ | Seeking Alpha | Jun 22, 2026 | neutral | 0 | 0.6 |
| Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year? - Yahoo Finance | Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 16, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals stock surges on diabetes trial results - Investing.com | Eledon Pharmaceuticals stock surges on diabetes trial results Investing.com | View source ↗ | Investing.com | Jun 8, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals (ELDN) Reports Promising Results for Tego - GuruFocus | Eledon Pharmaceuticals (ELDN) Reports Promising Results for Tego GuruFocus | View source ↗ | GuruFocus | Jun 8, 2026 | neutral | 0 | 0.6 |
| Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money - Yahoo Finance | Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money Yahoo Finance | View source ↗ | Yahoo Finance | Apr 20, 2026 | neutral | 0 | 0.6 |
| Eledon’s Transplant Drug Is Heading Toward A Phase 3 Moment - Finimize | Eledon’s Transplant Drug Is Heading Toward A Phase 3 Moment Finimize | View source ↗ | Finimize | Mar 16, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals, Inc. Common Stock (ELDN) Stock Price: Oct 8 Close $2.42 - Gotrade | Eledon Pharmaceuticals, Inc. Common Stock (ELDN) Stock Price: Oct 8 Close $2.42 Gotrade | View source ↗ | Gotrade | Feb 5, 2026 | neutral | 0 | 0.6 |
| Eledon Pharmaceuticals Faces Key Trials Amid Financial Struggles - StocksToTrade | Eledon Pharmaceuticals Faces Key Trials Amid Financial Struggles StocksToTrade | View source ↗ | StocksToTrade | Nov 8, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.